Content Summary
achieving good product quality. Yet corrective and preventive action failures are the most frequently cited problem by FDA officials for medical device companies, accounting for 21% of all observations noted during inspections in 2005.
And with industry giants receiving FDA injunctions for their inadequate CAPA processes, it seems that no one is invulnerable. By implementing these key strategies, your
company can avoid regulatory sanctions and reap the benefits of a streamlined CAPA system.
Access this content
Choose an option below
Your content has been opened.
Register to access this content
Verify your email to access this content
Code sent. Enter it in the modal
Your content has been opened.
Why do I need to verify I’m human?
Please verify you are a human before opening this content.
Your content has been opened.
The content will open in a new window. You may need to allow popups for this site.